Medical Terminology

sodium oxybate

« Back to Glossary Index

Sodium oxybate (Xyrem) is a medication taken at bedtime (and usually again during the night) that promotes deep sleep and improves daytime sleepiness in people with narcolepsy (although its effects in those with idiopathic hypersomnia are not as well characterized). It was approved by the U.S. FDA in 2002 for both cataplexy and excessive daytime sleepiness (the first generic version was approved in 2017). It is a central nervous system depressant, and is the sodium salt of gamma hydroxybutyric (GHB) which is an endogenous compound and a metabolite of the neurotransmitter GABA. Read more about sodium oxybate at HERE and on HF’s Treatment web page HERE.


The contents of this website, including text, graphics and other material, are for informational purposes only. This website is not intended to be a substitute for professional legal or medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Always consult your own attorney or other legal advisor with any legal questions you may have. The Hypersomnia Foundation does not recommend or endorse any specific tests, physicians, lawyers, legal advisors, products, procedures, opinions or other information referenced on this website. Reliance on any information on this website is solely at your own risk.

The Hypersomnia Foundation makes no representations or warranties about the satisfaction of any government regulations requiring disclosure of information on prescription drug products. In no event shall The Hypersomnia Foundation be liable for any damages (including without limitation incidental and consequential damages) or costs (including without limitation attorney’s fees) based on any claim arising from the use of this website and/or its content.